Cellosaurus cell line 3C5 [Mouse hybridoma against human PSCA] (CVCL

Cross-references
Cell line name	3C5 [Mouse hybridoma against human PSCA]
Accession	CVCL_B0TR
Resource Identification Initiative	To cite this cell line use: 3C5 [Mouse hybridoma against human PSCA] (RRID:CVCL_B0TR)
Comments	Group: Patented cell line. Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12616. Monoclonal antibody isotype: IgG2a, kappa. Monoclonal antibody target: UniProtKB; O43653; Human PSCA.
Species of origin	Mus musculus (Mouse) (NCBI Taxonomy: 10090)
Hierarchy	Parent: CVCL_D145 (HL-1 Friendly Myeloma-653)
Category	Hybridoma
Publications	PubMed=10713670; DOI=10.1038/sj.onc.1203426 Gu Z.-N., Thomas G., Yamashiro J., Shintaku I.P., Dorey F., Raitano A.B., Witte O.N., Said J.W., Loda M., Reiter R.E. Prostate stem cell antigen (PSCA) expression increases with high Gleason score, advanced stage and bone metastasis in prostate cancer. Oncogene 19:1288-1296(2000) PubMed=11226295; DOI=10.1073/pnas.051624698; PMCID=PMC30194 Saffran D.C., Raitano A.B., Hubert R.S., Witte O.N., Reiter R.E., Jakobovits A. Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts. Proc. Natl. Acad. Sci. U.S.A. 98:2658-2663(2001) Patent=US8524460 Reiter R.E., Witte O.N. PSCA: prostate stem cell antigen and uses thereof. Patent number US8524460, 03-Sep-2013
Encyclopedic resources	Wikidata; Q108819587
Entry history
Entry creation	23-Sep-2021
Last entry update	21-Mar-2023
Version number	3